Inhaled Fluticasone Effects on Upper Airway Patency in Obstructive Lung Disease

NCT01554488 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

25

Enrollment

FED

Sponsor class

Stopped Low subject accrual

Conditions

Asthma
Chronic Obstructive Pulmonary Disease
Obstructive Sleep Apnea

Interventions

DRUG: Inhaled Fluticasone Propionate

Sponsor

VA Office of Research and Development